ADDF-Harrington Scholar Program
Funds academic Alzheimer's researchers with hit-to-lead and development-stage support plus therapeutic guidance.
Eligibility · United States, Canada, United Kingdom
⚠This may reflect a past cycle — verify the current call on the funder's site.
The ADDF-Harrington Scholar Program is a joint initiative between the Alzheimer's Drug Discovery Foundation and the Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, designed to bridge the gap between academic discovery and pharmaceutical-grade drug development for Alzheimer's disease and related dementias. Unlike ADDF's broader RFPs, this is a dedicated scholar program th…
Hit-to-lead optimization through IND-enabling studies for Alzheimer's and related dementias. High-priority targets: proteostasis (autophagy, lysosomal) and senescence. No anti-amyloid or cholinesterase inhibitor approaches.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline